21 September 2017 | Statements

Seasonal Malaria Chemoprevention now underway in Burkina Faso, Chad, Nigeria

A child in Africa's Sahel region waits for Seasonal Malaria Chemoprevention (SMC) treatment (Image: Malaria Consortium)

A third season of Seasonal Malaria Chemoprevention (SMC) is now underway in Burkina Faso, Chad and Nigeria through the Unitaid-funded ACCESS-SMC project implemented by Malaria Consortium. A Unitaid delegation arrived in Burkina Faso today to monitor the project there.

Most childhood deaths from malaria in the region occur during the rainy season. SMC treatment during this period has proven to prevent illness and death from malaria.

This year, more than 15 million SMC treatments will be distributed to approximately 3.9 million children under five living in the three countries to protect them from malaria when they are most at risk, during the rainy season. Distributions will begin this month and continue until late October.


Read more: ACCESS-SMC website

View All News

Featured News

27 October 2021

WHO-Unitaid statement on the MPP licensing agreement for molnupiravir

Read More

06 October 2021

GAVI, Unitaid and the Global Fund welcome WHO recommendation for world’s first malaria vaccine

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.